Recombinant Viruses for Cancer Therapy

 Recombinant viruses area unit novel therapeutic agents that may be utilized for treatment of assorted diseases, as well as cancers. Recombinant viruses will be designed to precise foreign transgenes and have a broad reaction permitting organic phenomenon in an exceedingly wide selection of host cells. They can be designed for specific therapeutic goals. The recombinant viruses can be customizes to stimulate host response against tumor-specific antigens so that it can overcome the ability of the tumor to evade the host’s immune surveillance. Alternatively, recombinant viruses might categorical immunomodulatory genes that stimulate associate anti-cancer immune reaction

    Related Conference of Recombinant Viruses for Cancer Therapy

    April 16-17, 2021

    3rd World Congress on Gastroenterology

    Toronto, USA
    April 26-27, 2021

    16th Euro-Global Gastroenterology Conference

    London, UK
    May 26-26, 2021

    International Conference on Hepatitis

    London, UK
    June 14-15, 2021

    International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    June 14-15, 2021

    International Congress on Viral Hepatitis

    Rome, Italy
    July 13-14, 2021

    International Conference on Hepatitis & Liver diseases

    Shanghai, Australia
    July 20-21, 2021

    20th World Gastroenterologists Summit

    Osaka, Japan
    August 05-06, 2021

    Global Congress on Pancreas

    Zurich, Switzerland
    September 27-28, 2021

    8th Global Conference on Mass Spectrometry

    Tokyo, Japan
    September 28-29, 2021

    2 nd World Congress on Oil and Gas Engineering

    Auckland, Newzealand
    November 23-24, 2021

    World Conference on Digestive and metabolic diseases

    Hanoi, Vietnam

    Recombinant Viruses for Cancer Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in